| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pain | D010146 | 64 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Fatty Liver | D005234 | 48 associated lipids |
| Pain, Postoperative | D010149 | 13 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Uveitis | D014605 | 14 associated lipids |
Resolvin d1
Resolvin d1 is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 305 references associated with Resolvin d1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Resolvin d1
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Resolvin d1
PubChem Biomolecular Interactions and Pathways
All references with Resolvin d1
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Serhan CN et al. | Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. | 2004 | Prostaglandins Other Lipid Mediat. | pmid:15290791 |
| Hong S et al. | Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. | 2007 | J. Am. Soc. Mass Spectrom. | pmid:17055291 |
| Sun YP et al. | Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. | 2007 | J. Biol. Chem. | pmid:17244615 |
| Weylandt KH et al. | Lipoxins and resolvins in inflammatory bowel disease. | 2007 | Inflamm. Bowel Dis. | pmid:17262807 |
| Ariel A and Serhan CN | Resolvins and protectins in the termination program of acute inflammation. | 2007 | Trends Immunol. | pmid:17337246 |
| Haworth O and Levy BD | Endogenous lipid mediators in the resolution of airway inflammation. | 2007 | Eur. Respir. J. | pmid:17978156 |
| Chen Y et al. | Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases. | 2008 | Med. Hypotheses | pmid:18448265 |
| Merched AJ et al. | Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. | 2008 | FASEB J. | pmid:18559988 |
| Serhan CN | Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators. | 2008 | J. Periodontol. | pmid:18673006 |
| Kasuga K et al. | Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. | 2008 | J. Immunol. | pmid:19050288 |
| Jin Y et al. | Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. | 2009 | Invest. Ophthalmol. Vis. Sci. | pmid:19407006 |
| Spite M et al. | Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. | 2009 | Br. J. Pharmacol. | pmid:19422383 |
| Wendel M and Heller AR | Anticancer actions of omega-3 fatty acids--current state and future perspectives. | 2009 | Anticancer Agents Med Chem | pmid:19442044 |
| Tian H et al. | Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. | 2009 | Invest. Ophthalmol. Vis. Sci. | pmid:19443724 |
| Kaarniranta K and Salminen A | NF-kappaB signaling as a putative target for omega-3 metabolites in the prevention of age-related macular degeneration (AMD). | 2009 | Exp. Gerontol. | pmid:19751815 |
| Filep JG | Lipid mediator interplay: resolvin D1 attenuates inflammation evoked by glutathione-conjugated lipid peroxidation products. | 2009 | Br. J. Pharmacol. | pmid:19845687 |
| Marcheselli VL et al. | Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. | 2010 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:19931440 |
| Krishnamoorthy S et al. | Resolvin D1 binds human phagocytes with evidence for proresolving receptors. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20080636 |
| Levy BD | Resolvins and protectins: natural pharmacophores for resolution biology. | 2010 Apr-Jun | Prostaglandins Leukot. Essent. Fatty Acids | pmid:20227865 |
| Xu ZZ et al. | Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. | 2010 | Nat. Med. | pmid:20383154 |
| Yuan J et al. | The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20394833 |
| Sommer C and Birklein F | Fighting off pain with resolvins. | 2010 | Nat. Med. | pmid:20448572 |
| Bang S et al. | Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. | 2010 | Br. J. Pharmacol. | pmid:20880407 |
| Recchiuti A et al. | MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. | 2011 | FASEB J. | pmid:20956612 |
| Huang L et al. | Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. | 2011 | Pain | pmid:21255928 |
| Schif-Zuck S et al. | Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. | 2011 | Eur. J. Immunol. | pmid:21268007 |
| Dartt DA et al. | Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. | 2011 | J. Immunol. | pmid:21357260 |
| Lima-Garcia JF et al. | The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. | 2011 | Br. J. Pharmacol. | pmid:21418187 |
| Norling LV et al. | Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. | 2011 | J. Immunol. | pmid:21460209 |
| Hellmann J et al. | Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. | 2011 | FASEB J. | pmid:21478260 |
| Wang B et al. | Resolvin D1 protects mice from LPS-induced acute lung injury. | 2011 | Pulm Pharmacol Ther | pmid:21501693 |
| Palmer CD et al. | 17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli. | 2011 | J. Leukoc. Biol. | pmid:21653234 |
| Fredman G and Serhan CN | Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. | 2011 | Biochem. J. | pmid:21711247 |
| Bang S et al. | 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. | 2012 | Br. J. Pharmacol. | pmid:21718307 |
| Bento AF et al. | Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. | 2011 | J. Immunol. | pmid:21724996 |
| Ji RR et al. | Emerging roles of resolvins in the resolution of inflammation and pain. | 2011 | Trends Neurosci. | pmid:21963090 |
| Titos E et al. | Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. | 2011 | J. Immunol. | pmid:22013115 |
| Park CK et al. | Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. | 2011 | J. Neurosci. | pmid:22171045 |
| Odusanwo O et al. | Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation. | 2012 | Am. J. Physiol., Cell Physiol. | pmid:22237406 |
| Widgerow AD | Cellular resolution of inflammation--catabasis. | 2012 Jan-Feb | Wound Repair Regen | pmid:22276585 |
| Krishnamoorthy S et al. | Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. | 2012 | Am. J. Pathol. | pmid:22449948 |
| Norling LV et al. | Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. | 2012 | Arterioscler. Thromb. Vasc. Biol. | pmid:22499990 |
| Chiang N et al. | Infection regulates pro-resolving mediators that lower antibiotic requirements. | 2012 | Nature | pmid:22538616 |
| pmid:22610993 | ||||
| Eickmeier O et al. | Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. | 2013 | Mucosal Immunol | pmid:22785226 |
| Rogerio AP et al. | Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. | 2012 | J. Immunol. | pmid:22802419 |
| Clà ria J et al. | Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. | 2012 | J. Immunol. | pmid:22844113 |
| Dalli J and Serhan CN | Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. | 2012 | Blood | pmid:22904297 |
| Mas E et al. | Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. | 2012 | Clin. Chem. | pmid:22912397 |